Acetylsalicylic Acid Treatment in Patients With Sepsis and Septic Shock: A Phase 2, Placebo-Controlled, Randomized Clinical Trial
In this population of septic patients, ASA did not reduce the intensity of organ dysfunction. ASA increased the risk of severe bleeding compared with placebo.
Authors
- Bianca Silva Svicero (ORCID: https://orcid.org/0000-0002-9583-8206)
- Alexandre Biasi Cavalcanti (ORCID: https://orcid.org/0000-0003-2798-6263)
- Lucas Petri Damiani (ORCID: https://orcid.org/0000-0002-5836-3379)
- Fernanda Chohfi Atallah (ORCID: https://orcid.org/0000-0002-1337-1500)
- Daniere Yurie Vieira Tomotani (ORCID: https://orcid.org/0000-0002-8394-0270)
- Luciano César Pontes Azevedo (ORCID: https://orcid.org/0000-0001-6759-3910)
- Renato Jorge Alves (ORCID: https://orcid.org/0000-0002-2527-8717)
- Flávia Ribeiro Machado (ORCID: https://orcid.org/0000-0002-2356-4867)
- Fernando Godinho Zampieri (ORCID: https://orcid.org/0000-0001-9315-6386)
- Sandra Gomes de Barros Houly
- Maria Aparecida de Souza (ORCID: https://orcid.org/0000-0002-5393-024X)
- Francesco Serra
- Rodrigo C. Figueiredo
- Cíntia Loss Sartori Bustamante
- Fernando J. S. Ramos
- M Jackiu
- Thiago Miranda Lopes de Almeida
- Eduardo Souza Pacheco
- R. Schmidt
- Flávio Geraldo Rezende Freitas
Institutions
- Brazilian Research in Intensive Care Network (BR)
- Hospital de Santa Cruz (PT)
- Hospital e Maternidade Celso Pierro (BR)
- Hospital Sepaco (BR)
- Associação Paulista de Medicina (BR)
- Hospital São Paulo (BR)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Critical Care Medicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1097/ccm.0000000000006564
- Citations
- 4
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.42